Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,784 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
β-Endorphin Mediates the Development and Instability of Atherosclerotic Plaques.
Okano T, Sato K, Shirai R, Seki T, Shibata K, Yamashita T, Koide A, Tezuka H, Mori Y, Hirano T, Watanabe T. Okano T, et al. Among authors: yamashita t. Int J Endocrinol. 2020 Mar 28;2020:4139093. doi: 10.1155/2020/4139093. eCollection 2020. Int J Endocrinol. 2020. PMID: 32308678 Free PMC article.
Potent Vasoconstrictor Kisspeptin-10 Induces Atherosclerotic Plaque Progression and Instability: Reversal by its Receptor GPR54 Antagonist.
Sato K, Shirai R, Hontani M, Shinooka R, Hasegawa A, Kichise T, Yamashita T, Yoshizawa H, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T. Sato K, et al. Among authors: yamashita t. J Am Heart Assoc. 2017 Apr 14;6(4):e005790. doi: 10.1161/JAHA.117.005790. J Am Heart Assoc. 2017. PMID: 28411243 Free PMC article.
Neopterin Counters Vascular Inflammation and Atherosclerosis.
Shirai R, Sato K, Yamashita T, Yamaguchi M, Okano T, Watanabe-Kominato K, Watanabe R, Matsuyama TA, Ishibashi-Ueda H, Koba S, Kobayashi Y, Hirano T, Watanabe T. Shirai R, et al. Among authors: yamashita t. J Am Heart Assoc. 2018 Feb 2;7(3):e007359. doi: 10.1161/JAHA.117.007359. J Am Heart Assoc. 2018. PMID: 29420219 Free PMC article.
Chemerin-9, a potent agonist of chemerin receptor (ChemR23), prevents atherogenesis.
Sato K, Yoshizawa H, Seki T, Shirai R, Yamashita T, Okano T, Shibata K, Wakamatsu MJ, Mori Y, Morita T, Matsuyama TA, Ishibashi-Ueda H, Hirano T, Watanabe T. Sato K, et al. Among authors: yamashita t. Clin Sci (Lond). 2019 Aug 20;133(16):1779-1796. doi: 10.1042/CS20190336. Print 2019 Aug 30. Clin Sci (Lond). 2019. PMID: 31399499
Detection of late responders from non-responders to apremilast by simply measuring pruritus at week 4: results from a prospective cohort observational study.
Fukasawa T, Yoshizaki-Ogawa A, Enomoto A, Yamashita T, Miyagawa K, Sato S, Yoshizaki A. Fukasawa T, et al. Among authors: yamashita t. J Am Acad Dermatol. 2024 May 14:S0190-9622(24)00747-3. doi: 10.1016/j.jaad.2024.05.015. Online ahead of print. J Am Acad Dermatol. 2024. PMID: 38754631 No abstract available.
Neprilysin inhibition promotes skeletal growth via the CNP/NPR-B pathway.
Hakata T, Ueda Y, Yamashita T, Yamauchi I, Kosugi D, Sugawa T, Fujita H, Okamoto K, Fujii T, Taura D, Yasoda A, Akiyama H, Inagaki N. Hakata T, et al. Among authors: yamashita t. Endocrinology. 2024 May 16:bqae058. doi: 10.1210/endocr/bqae058. Online ahead of print. Endocrinology. 2024. PMID: 38752331
6,784 results